REPORT: Woman dies after receiving COVID-19 vaccine earlier in the day

A 78 year old Californian woman recently received the COVID-19 vaccination this Friday and died that same day after complaining of discomfort from vaccination shot. The woman lost consciousness shortly after her complaints.

The woman received the vaccination this past Friday through a Kaiser Permanente sponsored and run vaccination site at the Cal Poly Pomona Public University. Shortly after receiving the shot, she had complained of discomfort and lost consciousness. Immediately after, available medical experts performed CPR to revive the woman.  Health officials of Los Angeles County announced Saturday that no evidence exists that the vaccine was the cause of death. The County’s Department of Health stated that “there were no signs of allergic reactions.”

Dr. Michael E. Morris, director of Kaiser Permanente’s vaccination program mentioned the patient’s family told experts that “she had a history of heart illness”. The woman’s husband who also attended her in getting the vaccine himself, still plans on getting the second follow up vaccination to complete the recommended program. “On behalf of everyone involved in the vaccine site, led by Kaiser Permanente, we extend our sincere heartfelt condolences to her family,” Dr. Morris also said.

With the recent roll out of the Moderna and Pfizer vaccines late last year, many critics and skeptics of the COVID-19 vaccination programs are targeting cases similar to this patient’s as a means to discourage others from taking the vaccine. But health officials in the United States and across the globe are assuring people that the vaccines are safe and are encouraged as being a tool for beating the virus and its deadly spread. CDC officials also combat claims on the side effects that the vaccination brings, “You may have some side effects, which are normal signs that your body is building protection. These side effects may affect your ability to do daily activities, but they should go away in a few days.”




Leave a Reply